LSBCF (LakeShore Biopharma Co) Tax Provision: $0.13 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Tax Provision?

LakeShore Biopharma Co LSBCF Tax Provision is $0.13 Mil as of Mar. 2025.

LakeShore Biopharma Co's tax provision for the six months ended in Mar. 2025 was $0.30 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2025 was $0.13 Mil.

LakeShore Biopharma Co Tax Provision Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Tax Provision Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Tax Provision
-2.68 -0.78 -0.17 3.02 0.13

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Tax Provision Get a 7-Day Free Trial Premium Member Only -0.08 0.11 2.90 -0.17 0.30

LakeShore Biopharma Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of $0.13 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Tax Provision of $0.13 Mil as of Mar. 2025. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Tax Provision too high?
LakeShore Biopharma Co's current Tax Provision is $0.13 Mil.
How does LakeShore Biopharma Co's Tax Provision compare to ACUT and PPCB?
LakeShore Biopharma Co's Tax Provision of $0.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Biotechnology company?
A good Tax Provision depends on the Biotechnology industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Tax Provision is $0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Tax Provision of $0.13 Mil. The current Tax Provision is $0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Tax Provision is $0.13 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.